Making Propella Therapeutics a Wholly Owned Subsidiary Through Acquisition
An individual M&A transaction involving the execution of an acquisition agreement with Propella Therapeutics, completion of the acquisition on 21 December 2023, and its conversion into a wholly owned subsidiary.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.